Difference between revisions of "AM-2233"
From Wiki Weed
(Created page with "AM-2233 is a drug that acts as a highly potent full agonist for the cannabinoid receptors, with a Ki of 1.8nM at CB1 and 2.2nM at CB2 as the active (R) enantiomer. It...") |
|||
| Line 1: | Line 1: | ||
| − | AM-2233 is a drug that acts as a highly potent full agonist for the cannabinoid receptors, with a Ki of 1.8nM at | + | AM-2233 is a drug that acts as a highly potent full agonist for the cannabinoid receptors, with a Ki of 1.8nM at CB1 and 2.2nM at CB2 as the active (R) enantiomer. It was developed as a selective radioligand for the [[cannabinoid receptors]] and has been used as its 131I derivative for mapping the distribution of the [[CB1]] receptor in the brain. AM-2233 was found to fully substitute for [[THC]] in rats, with a potency lower than that of [[JWH-018]] but higher than [[WIN 55,212-2]]. |
Latest revision as of 17:21, 14 February 2015
AM-2233 is a drug that acts as a highly potent full agonist for the cannabinoid receptors, with a Ki of 1.8nM at CB1 and 2.2nM at CB2 as the active (R) enantiomer. It was developed as a selective radioligand for the cannabinoid receptors and has been used as its 131I derivative for mapping the distribution of the CB1 receptor in the brain. AM-2233 was found to fully substitute for THC in rats, with a potency lower than that of JWH-018 but higher than WIN 55,212-2.
